Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multifocal motor neuropathy.

Jean-Marc Léger1, Anthony Behin

  • 1consutation de Pathologie Neuro-Musculaire, Babinski Building, Salpêtrière Hospital, Paris, France. jean-marc.leger@psl.ap-hop-paris.fr

Current Opinion in Neurology
|September 13, 2005
PubMed
Summary

Multifocal motor neuropathy (MMN) is a distinct immune-mediated condition. While intravenous immunoglobulin shows efficacy, long-term treatment outcomes for MMN remain controversial, necessitating new therapeutic strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of diaphragm ultrasound and its diagnostic performance for predicting respiratory status in myotonic dystrophy type 1.

Respiratory medicine and research·2026
Same author

T-Cell Acute Lymphoblastic Leukemia in a Young Patient With Andersen-Tawil Syndrome Successfully and Safely Treated With Intensive Chemotherapy Including Potential Precipitating Drugs: A Case Report After 3.5 Years of Follow-up.

EJHaem·2026
Same author

Corrigendum to 'Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20' [Journal of the Neurological Sciences, 486 (2026) 125918].

Journal of the neurological sciences·2026
Same author

Diagnostic adjudication of potential participants with chronic inflammatory demyelinating polyradiculoneuropathy in the ADHERE trial of subcutaneous efgartigimod PH20.

Journal of the neurological sciences·2026
Same author

Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France.

Journal of neuromuscular diseases·2026
Same author

Laminopathies: natural history and risk prediction of heart failure.

European heart journal·2026

Area of Science:

  • Neurology
  • Immunology
  • Clinical Therapeutics

Background:

  • Multifocal motor neuropathy (MMN) is a rare immune-mediated disorder affecting peripheral nerves.
  • Distinguishing MMN from similar neuropathies like multifocal acquired demyelinating sensory and motor neuropathy (MADSAM) is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To critically review recent clinical and therapeutic studies on multifocal motor neuropathy.
  • To analyze the implications of current research for optimizing patient management strategies.

Main Methods:

  • Literature review of recent studies on multifocal motor neuropathy.
  • Analysis of clinical features, pathological findings, and treatment outcomes.

Main Results:

Related Experiment Videos

  • Recent studies confirm MMN as a distinct entity, differentiating it from MADSAM and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
  • Evidence supports the efficacy of intravenous immunoglobulins (IVIg) for MMN treatment, though long-term results are debated, with some studies showing deterioration and others sustained improvement.
  • Pathological studies highlight conduction block mechanisms and axonal degeneration in MMN.

Conclusions:

  • Multifocal motor neuropathy is a unique clinical entity with potential autoimmune mechanisms, suggested by anti-ganglioside GM1 antibodies and IVIg response.
  • Despite treatment benefits, long-term management of MMN requires further investigation due to controversial outcomes and the need for cost-effective strategies.